Fitbit Trackers to Help Breast Cancer Study

by Stephanie Tomsett | 3Q 2016 | IN-4196

The Dana-Farber Cancer Institute is partnering with Fitbit to take part in a 6-year study to see if losing weight could stop breast cancer from returning to patients. Approximately 20% of women with breast cancer experience a recurrence of the disease, and excess body weight has been linked to the increased risk; however it is a previously untested theory. The study started in August 2016, and involves 3,200 overweight and obese women with early-stage breast cancer who were found through oncology practices in the U.S. and Canada.

You must be a subscriber to view this Insight.

To find out more about subscribing:
Contact a representative about purchasing options.